Columbia China opens its third and largest hospital in Jiaxing, China
Retrieved on:
Saturday, October 23, 2021
MRI, Rehabilitation, Accrediting Commission International, Neurology, Research, OTS, Efficiency, Nephrology, Cardiology, DSA, Technology, CPM, National Association Medical Staff Services, Dermatology, Swire, Gynaecology, Patient, Temasek, General surgery, Intelligence, Joint Commission, Urology, Hospital, Learning, Endocrinology, JCI, Disability, Internal medicine, Columbia, Labour, GE, Gastroenterology, Pediatrics, CT 64, Women's health, Social responsibility, Population, Bed, Medical imaging, Health insurance, Medicine
JIAXING, China, Oct. 23, 2021 /PRNewswire/ -- Columbia China, a joint venture between Seattle's Columbia Pacific Management, Sheares Healthcare Group, a 100% owned subsidiary of Singapore investment company Temasek, and Hong Kong-based conglomerate Swire Pacific Limited, opens its third & largest 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province.
Key Points:
- JIAXING, China, Oct. 23, 2021 /PRNewswire/ -- Columbia China, a joint venture between Seattle's Columbia Pacific Management, Sheares Healthcare Group, a 100% owned subsidiary of Singapore investment company Temasek, and Hong Kong-based conglomerate Swire Pacific Limited, opens its third & largest 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province.
- The services provided at the Jiaxing Kaiyi Hospital include outpatient consultations, inpatient services, accident & emergency and health screening.
- "With the opening of its third and largest hospital, Columbia China aims to deliver the highest level of healthcare quality, service and patient experience to the 5.5m population in Jiaxing," said Bee Lan Tan, President & Group CEO of Columbia China.
- Columbia China is a privately-held Shanghai-based healthcare company jointly invested by Columbia Pacific Management (CPM) from the United States, Sheares Healthcare Group (SHEARES) from Singapore and Swire Pacific Limited from Hong Kong.